MB157 and MDA-MB-157 cell lines, both of which were derived from the same patient with triple-negative breast cancer, possess a NOTCH1 rearrangement associated with high levels of activated NOTCH1 protein and are also highly sensitive to Notch and pan-HDAC inhibitors (30, 105). The gene discussed is NOTCH1; the disease is triple-negative breast carcinoma.